Target intelligence / Profile preview

Tumor cell surface receptors and associated glycoproteins

Molecular classification
Receptor, Glycoprotein, Cell adhesion molecule, Enzyme, Ion channel
01

Overview

Tumor cell surface receptors and associated glycoproteins represent a broad and heterogeneous category of proteins and conjugated carbohydrates expressed on the plasma membrane of malignant cells. These molecules serve critical roles in the oncogenic process, including the mediation of growth factor signaling, cell-to-cell adhesion, and the modulation of the tumor microenvironment to facilitate immune evasion. While many of these proteins are also found on normal cells, they are often overexpressed, mutated, or aberrantly glycosylated in cancer, making them primary targets for therapeutic intervention. Common examples within this category include the epidermal growth factor receptor (EGFR) family, various mucins like MUC1, and specific glycoproteins such as TAG-72. Because this term describes a diverse class of molecules rather than a single biological entity, it is generally considered a functional grouping used in oncology research rather than a specific therapeutic target.

Other names
Tumor-associated antigensCancer cell surface markersTumor-specific antigensTumor-associated glycoproteins
02

Mechanism of action

Various mechanisms including signal inhibition, antibody-dependent cellular cytotoxicity (ADCC), and drug delivery via conjugation.

03

Biological functions

Signal transductionCell-cell communicationCell adhesionImmune evasionMetabolism
04

Disease associations

Cancer
05

Safety considerations

Off-target toxicity due to expression on healthy tissuesAntigenic drift or lossImmune-related adverse events

Beyond the preview

Go deeper on Tumor cell surface receptors and associated glycoproteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor cell surface receptors and associated glycoproteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call